Serum CD44 Levels Preceding the Diagnosis of Non-Hodgkin's Lymphoma

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Leukemia and Lymphoma

• Publication date

  2000-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/10428190009058511PMID 11042519
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Significant Elevation of Tumour-Associated Isoforms of Soluble CD44 in Serum of Normal Individuals Caused by Cigarette Smoking

  1997cited by this paper
• CD44 as a marker in human cancers.

  1997cited by this paper
• Elevated serum CD44 level is associated with unfavorable outcome in non-Hodgkin's lymphoma.

  1997cited by this paper
• Origin and function of circulating CD44 in non-Hodgkin's lymphoma.

  1997cited by this paper
• Soluble CD44 isoforms in serum as potential markers of metastatic gastric carcinoma.

  1996cited by this paper
• CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor

  1995cited by this paper
• Serum CD44 splice variants in cervical cancer patients.

  1995cited by this paper
• CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.

  1995cited by this paper
• Serum CD44 in malignant lymphoma: an association with treatment response.

  1994cited by this paper
• A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

  1994cited by this paper
• Serum Cd44 in Malignant Lymphoma: an Association with Treatment Response

  1994cited by this paper
• The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.

  1994cited by this paper
• Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer.

  1994cited by this paper
• Characterization of soluble CD44 in the circulation of mice. Levels are affected by immune activity and tumor growth.

  1994cited by this paper
• Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas.

  1993cited by this paper
• Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression.

  1993cited by this paper
• CD44 and its interaction with extracellular matrix.

  1993cited by this paper
• Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

  1992cited by this paper
• The Kiel Classification

  1992cited by this paper
• Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons

  1991cited by this paper
• Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma.

  1991cited by this paper
• A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

  1991cited by this paper
• Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway.

  1990cited by this paper
• Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long- term bone marrow cultures

  1990cited by this paper
• Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types

  1989cited by this paper
• CD44--a molecule involved in leukocyte adherence and T-cell activation.

  1989cited by this paper
• Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man.

  1988cited by this paper
• Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells

  1987cited by this paper
• A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man

  1986cited by this paper
• Report of the Committee on Hodgkin's Disease Staging Classification.

  1971cited by this paper

• Ultra-wide, attomolar-level limit detection of CD44 biomarker with a silanized optical fiber biosensor.

  2022cites this paper
• All-thermoplastic nanoplasmonic microfluidic device for transmission SPR biosensing.

  2013cites this paper
• Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas

  2012cites this paper
• Soluble CD44 Interacts with Intermediate Filament Protein Vimentin on Endothelial Cell Surface

  2011cites this paper
• Evaluation of some biochemical markers as prognostic factors in malignant lymphoma.

  2008cites this paper
• CD44 Attenuates Metastasis During Breast Cancer Progression

  2008cites this paper
• CD44 in Cancer

  2002cites this paper